February 11th 2025
The long-held practice is effective in pinpointing the emergence of known and unknown risks to clinical development, study shows.
December 20th 2024
Ken Getz of Tufts CSDD Discusses RBQM Study Conducted with CluePoints and PwC
May 10th 2024In part 1 of this video interview series with Ken Getz, executive director and research professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine and Steve Young, chief science officer, CluePoints, Getz touches on the findings from a recent study on RBQM adoption.
Industry Assessment of Risk-Based Quality Management Emphasizes Value of Adoption
April 4th 2024A study conducted by the Tufts CSDD in collaboration with CluePoints and PwC revealed that slightly more than half of sponsors and contract research organizations have adopted risk-based quality management approaches.